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Internalization of calcium oxalate crystals by renal tubular cells:
A nephron segment–specific process?
Background. Crystal retention in the kidney is caused by
the interaction between crystals and the cells lining the renal
tubules. These interactions involve crystal attachment, fol-
lowed by internalization or not. Here, we studied the ability
of various renal tubular cell lines to internalize calcium oxalate
monohydrate (COM) crystals.
Methods. Crystal-cell interactions are studied by light-, elec-
tron-, and confocal microscopy with cells resembling the renal
proximal tubule [porcine kidney (LLC-PK1)], proximal/distal
tubule [Madin-Darby canine kidney II (MDCK-II)], and distal
tubule and/or collecting ducts [(Madin-Darby canine kidney I
(MDCK-I), rat cortical collecting duct 1 (RCCD1)]. Crystal-
binding strength and internalization are characterized and
quantified with radiolabeled COM.
Results. Microscopy studies showed that crystals were firmly
embedded in the membranes of LLC-PK1 and MDCK-II cells
to be subsequently internalized. On the other hand, crystals bound
only loosely to MDCK-I and RCCD1 and were not taken up
by these cells. Crystal uptake by LLC-PK1 and MDCK-II, ex-
pressed ing/106 cells, is temperature-dependent and gradually
increases from 0.88 and 0.15 in 30 minutes, respectively, to 4.70
and 3.85, respectively, after five hours, whereas these values
never exceeded background levels in MDCK-I and RCCD1 cells.
Conclusion. The adherence of COM crystals to renal cells
with properties of the proximal tubule is inevitable and actively
followed by their uptake, whereas crystals attached to cells
resembling the distal tubule and/or collecting duct are not
internalized. Since crystal formation usually occurs in segments
beyond the renal proximal tubule, crystal uptake may be of
less importance in the etiology of idiopathic calcium oxalate
stone disease.
Kidney stones are composed of myriad microliths
pasted with organic material. Although most stones are
found in the renal pelvis, the stone-forming process actu-
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ally starts already in the nephrons. Crystals are fre-
quently precipitated in the renal tubular fluid of stone-
forming as well as non-stone–forming individuals [1].
Following their formation in the nephron, the crystals are
rapidly covered with inhibitors of crystallization, which
facilitates their excretion [2]. This elimination process is
thwarted, however, when the crystals adhere to the tubu-
lar lining [3]. Several investigators in the past have pro-
posed the concept that the onset of nephrolithiasis lies
within the nephron. More than 30 years ago, Malek and
Boyce [4] collected renal biopsies from idiopathic cal-
cium oxalate stone formers who underwent nephroli-
thotomy, and from patients who were operated for other
renal disorders. They found microliths lying in nephrons
of all stone formers, whereas intranephronic calculosis,
as this phenomenon was called, was observed in only a
minority of the non-stone formers. Later, Hering et al
[5] found microliths inside the renal collecting ducts of
stone formers who required nephrectomy. More re-
cently, Lieske et al [6] not only found intranephronic
crystals in renal biopsies of a patient with type I primary
hyperoxaluria, but strikingly they also found crystals in-
side renal tubular cells. Cell culture studies subsequently
showed that calcium oxalate monohydrate (COM) crystals
were taken up by renal tubular cells, and that this process
stimulated cell proliferation [7, 8]. On the basis of these
results, the authors proposed that this response of renal
cells to crystals could play a role in the development of
kidney stones. Although we extensively studied the ad-
herence of COM crystals to renal tubule epithelial cells
in culture, crystal uptake received little attention. The
polysaccharide hyaluronan (HA) was identified as a ma-
jor crystal-binding molecule at the surface of Madin-
Darby canine kidney (MDCK) strain I cells in locomo-
tion, whereas HA-negative quiescent cells in confluent
cultures are nonadherent [9]. The level of crystal binding
to rat cortical collecting duct (RCCD1) cells also signifi-
cantly decreased during their growth to confluence (un-
published observations). Crystal binding to porcine kidney
(LLC-PK1) and Madin-Darby canine kidney II (MDCK-II)
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cells is quite different because, irrespective of their stage
of development, these cells constitutively express crystal-
binding molecules [10]. The present investigation was
conducted to study the ability of various cell types to
internalize calcium oxalate crystals.
METHODS
Cell culture
MDCK-I and MDCK-II cells [11] were kindly pro-
vided by Prof. G. van Meer (Laboratory for Cell Biology
and Histology, Amsterdam Medical Center, The Nether-
lands). LLC-PK1 cells were obtained from the American
Type Culture Collection (ATCC). Routinely, the cells were
grown in Dulbecco’s modified Eagle’s medium (DMEM)
(Gibco, Grand Island, NY, USA) supplemented with
10% fetal calf serum (FCS) (PAA Labs, Linz, Austria)
and replated weekly. RCCD1 cells [12] were kindly pro-
vided by Dr. M. Blot-Chabaud (INSERM U246, Faculte´
de Me´decine Xavier Bichat, Paris, France). Routinely,
these cells were grown in DMEM/F12 supplemented
with 14 mmol/L NaHCO3, 2 mmol/L glutamine, 5 g/mL
transferrin, 5 g/mL insulin, 1.3 ng/mL sodium selenite,
10 g/mL epidermal growth factor (EGF), 5  108
mmol/L T3, 10 U/mL penicillin-streptomycin, and 2%
FCS in collagen-coated flasks (collagen-G; 100 g/mL,
Biochrom KG, Berlin, Germany) and replated weekly.
Most studies described in the present investigation were
obtained using subconfluent cultures. The rationale to
use subconfluent cultures was that crystals do not adhere
to collecting duct cells populating confluent cultures,
which makes it impossible to study crystal binding and
uptake at that stage of epithelial development. To obtain
subconfluent cultures, cells were seeded at a plating den-
sity of 1  106 cells on 24 mm polycarbonate porous
filter inserts (Corning Costar, Badhoevedorp, The Neth-
erlands). RCCD1 cells were grown on collagen-coated
inserts. Two days postseeding, the inserts contain on
average 1 to 2  106 cells. We considered these cultures
subconfluent as it takes a few more days before the
maximal amount of cells per insert (3 to 4  106 cells)
and the maximal transepithelial electrical resistances
(TER) are reached [11, 12]. Routinely, polymerase chain
reaction (PCR) analyses were performed on DNA iso-
lated from cell culture–conditioned medium for the pres-
ence of mycoplasma. Cells used in this study were not
contaminated with mycoplasma.
Crystal formation
A solution of sodium oxalate was prepared by adding
10 L 37 MBq/mL [14C] oxalic acid (Amersham Interna-
tional plc, Buckinghamshire, UK) to 0.25 mL 200
mmol/L sodium oxalate. A calcium chloride solution was
prepared by adding 0.25 mL 200 mmol/L calcium chlo-
ride to 9.5 mL distilled water. Mixing the two solutions
at room temperature (final concentration of 5 mmol/L
for both oxalate and calcium) immediately resulted in
the nucleation of radiolabeled COM. After settling for
three days, crystals were washed three times with, and
resuspended in, CaOx-saturated H2O in a final volume
of 5 mL (1.46 mg COM crystals/mL). The same proce-
dure but without [14C] oxalic acid was used for the gener-
ation of nonradiolabeled COM. The crystals had an aver-
age size of 1 to 2 m [13]. For the light (phase-contrast)
microscopy studies we used a slightly different protocol
in which the final concentration of both calcium and
oxalate was 1 mmol/L, which resulted in larger crystals
with an average size between 5 to 6 m [11].
Phase-contrast microscopy
Twenty-four hours postseeding on solid growth sub-
strates, crystals were added to proliferating small islands
of cells and allowed to adhere for 30 minutes, after which
all nonadhered crystals were removed and the cell sur-
face–associated crystals inspected (magnification, 200)
under a phase-contrast microscope (Axiovert 25) cou-
pled with an AxioCam camera scanner (Carl Zeiss Vision
GmbH, Munchen-Hallbergmoos, Germany).
Scanning electron microscopy
Cells cultured on porous supports were fixed in 2.5%
glutaraldehyde in 0.15 mol/L cacodylate buffer for 4
hours. After washing in 0.1 mol/L cacodylate buffer for
3 hours, the samples were postfixed in OsO4 in 0.1 mol/L
cacodylate buffer for 4 hours, washed again in cacodylate
buffer for 3 hours, dehydrated in a graded series of etha-
nol, and finally critical point dried. After mounting on
stubs, a conductive layer was sputter coated on the sam-
ples and examined in a Philips SEM 525 (Philips, Eindho-
ven, The Netherlands) (magnification, 20,000).
Transmission electron microscopy
Cells were fixed in 1.5% (vol/vol) glutaraldehyde in
0.1 mol/L of cacodylate/HCl buffer for 1 hour at 37C.
After aldehyde fixation, cells were postfixed in 1%
(weight/vol) OsO4 in the same buffer system, to which
K4Fe(CN6).3H2O was added to a final concentration of
0.05 mol/L for 1 hour at room temperature. The cells
were routinely dehydrated and embedded in Epon. Ul-
trathin sections (30 to 50 nm) were sectioned with dia-
mond knives, collected on unfilmed 400 mesh copper
grids, and inspected in a Zeiss EM 902 transmission
electron microscope (Zeiss, Oberkochen, Germany) op-
erating at 80 kV (magnification, 2500).
Crystal binding
Radiolabeled crystals were added to the cultures and
allowed to adhere for 1 hour, after which the inserts
were extensively rinsed to remove all nonassociated crys-
tals, cut out, and counted in a liquid scintillation counter
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(Packard, Meriden, CT, USA). The number of associ-
ated crystals was calculated from the disintegrations per
minute (dpm)/filter [9]. The effect of hyaluronan removal
on crystal-cell association was studied by treating the
monolayers with 5 U/mL Streptomyces hyaluronidase
(E.C. 3.2.1.35; Sigma-Aldrich Chemie, Zwijndrecht, The
Netherlands) in serum-free DMEM, pH 5.3 at 37C for
1 hour before the addition of radiolabeled crystals. Then
crystal-binding measurements were performed as de-
scribed above. Experiments were performed to examine
the firmness of crystal binding. Cultures were incubated
with [14C] COM crystals for 1 hour. After removal of non-
adhered crystals by extensive washings, the cells were
treated for 10 minutes with either 70% ethanol or with
a mixture of 3.7% formaldehyde/0.1% glutaraldehyde.
Released crystals were removed, the inserts cut out, and
the remaining cell-associated radioactivity counted. All
[14C]COM binding experiments were repeated at least
three times, using three independent inserts per group.
Confocal laser scanning microscopy
A combination of light reflection (to visualize the crys-
tals) and fluorescent-labeled phalloidin (to visualize the
cells) was used to monitor the fate of cell-associated
crystals by confocal microscopy. In time-lapse studies,
nonradiolabeled COM crystals were incubated with sub-
confluent cultures for the indicated periods of time at
37C and 4C. All nonattached crystals were removed
by extensive washings and the cells were fixed for 10
minutes with formaldehyde (3.7%), followed by mem-
brane permeabilization with 70% ethanol for 10 minutes.
The inserts were then washed, cut out, and incubated
for 15 minutes with 2 g/mL fluorescein isothiocyanate-
conjugated (FITC) phalloidin (Sigma-Aldrich Chemie),
washed two times with phosphate-buffered saline (PBS),
and mounted in Vectashield (Vector Laboratories, Burl-
ingame, CA, USA). A 488 nm argon laser was used to
excite the FITC-phalloidin. The extra- and/or intracellu-
lar localization of the crystals was detected by 633 nm
(red) Kr-laser light reflection. A 560 nm beam splitter
separated the FITC emission signal and the 633 nm signal
reflected by the crystals. The FITC signal was passed
through a 510 to 540 nm band-pass filter to block the
reflection from the 488 nm laser. No blocking filter was
used for the light reflection signal. The mounted inserts
were extensively inspected and images (magnification,
63) were made of at least 10 random fields per insert
with a Zeiss LSM 410 laser scanning confocal microscope
(Zeiss), from which representative images were selected.
Experiments were repeated at least three times.
Quantification of crystal internalization
To assess if cell surface–associated crystals could be
internalized, [14C]COM crystals were added and incu-
bated for the indicated periods of time, after which all
nonadhered crystals were washed away. The cells were
Fig. 1. Phase-contrast microscopy. Crystals associated with small
groups of proliferating Madin-Darby canine kidney strain I (MDCK-I),
Madin-Darby canine kidney strain II (MDCK-II), and porcine kidney
(LLC-PK1) cells. The crystals cover the entire surface of MDCK-II and
LLC-PK1, whereas they seem to be restricted to the periphery of
MDCK-I (magnification, 200). The bar graph in the lower righthand
corner depicts the effect of hyaluronidase treatment on [14C] calcium
oxalate monohydrate (COM) binding. Open bars represent control;
filled bars represent hyaluronidase. *P  0.05 is statistically significant
compared to control.
subsequently treated for 5 to 10 minutes with 0.25%
trypsin to digest cell surface glycoconjugates and thereby
release most of the crystals attached to the cell exterior.
TER measurements indicated that this mild enzyme
treatment did not yet release the cells from each other or
from the growth substrate. This method does not discrimi-
nate between crystals that are halfway through the mem-
brane and those that are entirely inside the cell. With
this restriction in mind, we considered the remaining cell-
associated radiolabeled crystals as internalized.
RESULTS
Phase-contrast microscopy
The adherence of COM crystals to proliferating cells
was viewed using light microscopy. These observations
showed remarkable differences in the manner by which
crystals were attached to LLC-PK1 and MDCK-II com-
pared to MDCK-I cells. The crystals appeared to be
lying flat on the surface of the cell islands formed by
LLC-PK1 and MDCK-II. On the other hand, crystals
were predominantly found at the periphery of the cell
groups formed by MDCK-I (Fig. 1). These observations
prompted us to inspect the attachment of crystals to
these cell types more closely.
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Fig. 2. Scanning electron microscopy (SEM).
(A ) SEM image of calcium oxalate monohy-
drate (COM) crystals generated by 5 mmol/L
of both calcium and oxalate. (B ) SEM image
of the surface of Madin-Darby canine kidney
strain II (MDCK-II) cells cultured on porous
supports, showing numerous microvilli. (C )
The same cells, but after incubation with COM
crystals (magnification, 20,000). (D ) Trans-
mission electron microscopy (TEM) image of
COM crystal ghosts inside MDCK-II (magni-
fication, 2500).
Crystal binding
Hyaluronan (HA) is one of the major crystal-binding
molecules at the surface of MDCK-I cells [9]. To deter-
mine whether HA also plays a role in crystal binding to
LLC-PK1 and MDCK-II, these cells were treated with
Streptomyces hyaluronidase prior to incubating subcon-
fluent cultures with radiolabeled COM crystals. Hyal-
uronidase significantly reduced the level of binding to
MDCK-I cells, whereas this enzyme had no or negligible
effect on crystal binding to LLC-PK1 and MDCK-II cells
(Fig. 1).
Electron microscopy
Electron microscopy (EM) images were made to study
the interaction between crystals and the different cell
types more in detail. Scanning electron microscopy
(SEM) images showed the attachment of COM crystals
to the surface of MDCK-II cells (Fig. 2) that is abun-
dantly covered with microvilli (Fig. 2). Figure 2 suggests
that the crystals became embedded in the plasma mem-
brane and even entered the cells. Similar results were
obtained with LLC-PK1 (not shown). SEM images of
crystal binding to MDCK-I cells were entirely different,
however. Although our standard [14C]COM crystal-bind-
ing studies indicated that relatively large amounts of
crystals were able to bind to proliferating MDCK-I, these
crystals were hardly recovered in the SEM images. This
suggests that these crystals are lost somewhere during
preparation, a process that requires extensive washing
steps. To assess if crystals actually entered certain cell
types, the cells were incubated for two hours with COM
crystals, after which single cell suspensions were pre-
pared with trypsin to be inspected by transmission elec-
tron microscopy (TEM). These images indeed provided
evidence for the presence of crystals inside MDCK-II
cells in the form of so-called ghosts (Fig. 2). Crystal
ghosts were also seen in LLC-PK1 cells but never inside
MDCK-I cells (not shown).
Effect of fixatives and enzymes on the release of cell
surface–associated [14C]COM
The presence in the SEM images of crystals at the
surface of LLC-PK1 and MDCK-II cells, and their ab-
sence from MDCK-I, as well as the adherence of crystals
to these cells under phase-contrast microscopy, suggests
that there are differences in the way by which crystals
attach to these cell types. To test this concept, radiolabeled
COM crystals were allowed to adhere to the various
cell types, after which the cells were treated either with
ethanol to dehydrate the cell surface or with formalde-
hyde/glutaraldehyde to cross-link membrane proteins.
These treatments released relatively large amounts of
crystals from MDCK-I. Ethanol had the most profound
effect and liberated approximately 60% of the cell sur-
face–associated [14C]COM, whereas formaldehyde/glu-
taraldehyde released about 40% of adhered crystals. Nei-
ther fixation method, however, significantly liberated
crystals from MDCK-II or LLC-PK1 cells (Table 1).
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Table 1. Effect of fixatives on the release of prebound COM crystals
Formaldehyde/
Untreated Ethanol glutaraldehyde
MDCK-I 1005 396a 606a
MDCK-II 10012 924 886
LLC-PK1 1005 987 876
Abbreviations are: COM, calcium oxalate monohydrate; LLC-PK1, porcine
kidney ; MDCK-I, Madin-Darby canine kidney strain I; MDCK-II; Madin-Darby
canine kidney strain II. Subconfluent cultures formed by LLC-PK1, MDCK-II,
and MDCK-I cells preincubated with [14C]COM crystals for one hour were
treated for 10 minutes with ethanol or formaldehyde/glutaraldehyde to study the
release of radiolabeled crystals. Results are expressed as percentage of crystals
remaining associated with the cells. AverageSD of three independent inserts.
Statistical analysis was performed using Mann-Whitney test.
a Significantly different compared to control (P  0.05)
Confocal microscopy
To assess the fate of cell surface–associated crystals,
we performed time-lapse studies using confocal micro-
scopy. Nonradiolabeled COM crystals were added to
subconfluent cultures formed by the various cell lines.
Confocal images made perpendicular to the cell surface
showed that after half an hour at 37C, crystals were
exclusively located at the surface of all cell types. After
90, 180, and 300 minutes, however, crystals were found
inside LLC-PK1 and MDCK-II cells unless they were
kept in the cold (300 minutes, 4C), indicating that crystal
uptake is an active process. It should be noted that crys-
tals were also taken up by confluent LLC-PK1 and
MDCK-II cells, indicating that the uptake of crystals was
not crucially dependent on their stage of development
(not shown). In contrast, crystals were never found inside
MDCK-I cells. Since MDCK-I cells form hyaluronan-
rich cell coats [3, 24], it cannot be excluded that these coats
make crystal internalization impossible by preventing
the crystals from directly contacting the cell surface. Con-
focal images, however, revealed that crystals were also
not taken up by cells that were made coat-free with
hyaluronidase prior to the addition of crystals (not shown).
To examine whether the inability to take up crystals
could be an intrinsic property of late nephron cell types,
crystal uptake was studied in RCCD1, another renal col-
lecting duct cell line. The vast majority of the RCCD1
cells also did not internalize COM crystals (Fig. 3).
Quantification of crystal internalization
Experiments were performed to quantify crystal up-
take. In time-lapse studies, radiolabeled COM crystals
were allowed to interact with the cells. The cultures
were subsequently briefly treated with trypsin to release
crystals attached to the cell surface. The amount of
MDCK-II–associated [14C]COM that could not be re-
leased from the cells with trypsin gradually increased
from background levels of 0.15  0.03 g/106 cells at 30
minutes to 3.85  0.04 g/106 cells after 300 minutes
(Fig. 4), indicating crystal internalization. Crystals were
also taken up by LLC-PK1, but with a somewhat different
time course. Uptake showed a steep rise from 0.88 0.11
to 3.23  0.21 g/106 cells between 30 and 90 minutes,
followed by a slower increase to 4.70  0.77 g COM
crystals per million LLC-PK1 cells in the next hours. More
than 90% of the [14C]COM associated with MDCK-I was
released by trypsin at all time points, and the amount
of radiolabeled COM that remained associated with the
cell surface after enzyme treatment never reached values
above background (0.4 g/106 cells). We speculated
that the polymer hyaluronan, the major binding sub-
stance at the surface of MDCK-I, might have prevented
the crystals from contacting the membrane. To find out
if the cell surface expression of hyaluronan is responsible
for the inability of MDCK-I cells to take up crystals,
uptake was measured by cells that were pretreated with
hyaluronidase. The uptake assay demonstrated that crys-
tals that were able to bind to MDCK-I after hyaluroni-
dase treatment also did not enter the cells (not shown).
[14C]COM uptake studies performed with RCCD1 cells
showed that even after an incubation period of five hours
at 37C, more than 90% of the crystals associated with
the cell surface could be removed with trypsin. In the
time-lapse studies the amount of crystals internalized by
RCCD1 never exceeded background levels (Fig. 4).
DISCUSSION
This study shows that the adherence of calcium oxalate
monohydrate (COM) crystals to renal tubular cells is not
necessarily followed by crystal uptake. Although crystals
avidly bind to subconfluent LLC-PK1, MDCK-II, MDCK-I,
and RCCD1 cells, they are eagerly internalized by LLC-
PK1 and MDCK-II, but not by MDCK-I and RCCD1.
Light microscopy images showed that crystals entirely
covered the surface of LLC-PK1 and MDCK-II cells,
whereas their adherence to MDCK-I cells seemed to be
restricted to the cell periphery (Fig. 1). Using radiola-
beled COM it was demonstrated that, once attached to
the surface of LLC-PK1 or MDCK-II, only few crystals
are liberated by fixation methods such as dehydration
or protein crosslinking (Table 1). Moreover, brief treat-
ment with trypsin did not liberate many of the crystals
attached to these two cell types. Hence, COM crystals
became firmly anchored to the surface of LLC-PK1 and
MDCK-II cells. Electron microscopy images showed that
crystals indeed became tightly embedded in the plasma
membrane to ultimately end up inside these cells (Fig. 2).
These observations were confirmed by a [14C]COM up-
take assay, showing that the internalization of crystals by
LLC-PK1 and MDCK-II cells is temperature- and time-
dependent (Fig. 4). Previously, we identified the poly-
saccharide hyaluronan (HA) as an important crystal-
binding molecule at the surface of MDCK-I cells [9].
However, pretreatment of LLC-PK1 and MDCK-II cells
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Fig. 3. Confocal laser scanning microscopy (CLSM). The cells are visualized using phalloidin-fluorescein isothiocyanate (FITC) (green), and
calcium oxalate monohydrate (COM) by light reflection (red). (A ) Subconfluent cells with surface properties of the proximal tubule [Madin-Darby
canine kidney strain II (MDCK-II) and porcine kidney (LLC-PK1)] internalize crystals unless they are kept at 4C. (B ) Subconfluent cells with
surface properties of the distal tubule and/or collecting ducts [Madin-Darby canine kidney strain I (MDCK-I) and rat cortical collecting duct strain
1 (RCCD1)] do not internalize crystals. Note that although the cultures appear to be confluent we consider them subconfluent because the number
of cells per insert is still increasing and the tight junctions have not yet been fully developed (magnification, 63).
Fig. 4. Quantitative crystal uptake assay. Subconfluent cultures were
incubated with [14C]calcium oxalate monohydrate (COM) for increasing
periods of time, after which all nonadhered crystals were removed by
extensive washings. The cells were then briefly treated with trypsin to
liberate crystals associated with the cell surface but not incorporated
in the plasma membrane. Remaining cell-associated crystals are consid-
ered to be internalized. The uptake of crystals by Madin-Darby canine
kidney strain II (MDCK-II) is linear between 30 and 300 minutes (),
whereas crystal internalization by porcine kidney (LLC-PK1) cells shows
a steep rise in the first 90 minutes, followed by a more gradual increase
thereafter (). Crystals are not taken up by Madin-Darby canine kidney
strain I (MDCK-I) () or rat cortical collecting duct strain 1 (RCCD1)
(). Average  SD of three independent inserts of a representative
experiment.
with hyaluronidase did not affect the affinity of these
cell types for crystals, indicating that this form of binding
does not depend on HA (Fig. 1). Crystals became only
loosely attached to MDCK-I cells. Fixation or short tryp-
sin treatment liberated most of the crystals bound to these
cells. The affinity of MDCK-I cells for COM crystals is
significantly reduced after pretreatment with hyaluroni-
dase [9]. The quantitative uptake assay confirmed that
MDCK-I cells are unable to internalize COM crystals.
The possibility that uptake is impeded by HA coats was
canceled out by the observation that crystals also did
not enter MDCK-I cells that were treated with hyaluron-
idase prior to the addition of crystals (not shown). COM
crystals also were not taken up by RCCD1 cells. Although
an occasional RCCD1 cell contained a crystal, the quanti-
tative uptake assay clearly demonstrated that the COM
crystal uptake by RCCD1 cells is negligible. Collectively,
these data show that crystals are taken up by LLC-PK1
and MDCK-II, but not by MDCK-I and RCCD1.
LLC-PK1 and MDCK-II cells exhibit many character-
istics of the renal proximal tubule. Confluent monolayers
formed by these cells are leaky (200  · cm2), are en-
dowed with a luxurious brush border packed with tall
microvilli, and their membranes express high levels of
alkaline phosphatase (AP) and -glutamyltranspepti-
dase (-GT) activity [10]. In addition, LLC-PK1 cells
actively transport essential nutrients and water across
the epithelium [14]. MDCK-I and RCCD1 cells, on the
other hand, resemble the renal collecting ducts in many
respects. MDCK-I cells, isolated from the original MDCK
cell line, develop a high transepithelial electrical resistance
(	10,000  · cm2), are covered with short and stubby
microvilli and express low levels of AP and -GT [10].
MDCK-I exhibits significant carbonic anhydrase activity
[15] and its inward current can be activated by vasoactive
intestinal polypeptide [16]. RCCD1 cells are isolated
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from rat collecting ducts; this cell line is also character-
ized by high transepithelial resistances (	3000  · cm2)
and specific hormonal sensitivities. Their morphologic
appearance resembles that of intact cortical collecting
duct (CCD) [12]. On the basis of these results it is specu-
lated that the ability of renal tubular cells to internalize
crystals depends upon their segmental origin.
Up until now, crystal uptake studies have been pre-
dominantly performed with cells resembling the renal
proximal tubule. Lieske et al [17], for example, observed
that African green monkey BSC-1 or parental MDCK
(ATCC) cells rapidly took up calcium oxalate crystals.
However, little is known about the segmental origin of
BSC-1, whereas the original MDCK cell line contains
various cell types, including proximal tubular cells [12].
Crystal uptake has been further studied in the proximal
tubular opossum kidney cell line, OK-1 [18], and again
by several investigators in the original MDCK cell line
[19–21]. Thus, these results are in agreement with those
obtained with LLC-PK1 and MDCK-II in the present
study.
In vivo, the uptake of crystals followed by their translo-
cation to the renal interstitium is typical for animals fed
a stone-inducing diet, or for primary human forms of
chronic hyperoxaluria [6, 22, 23]. In rats, hyperoxaluria
is commonly generated by the addition of oxalate precur-
sors such as ethylene glycol to the drinking water. Stone-
inducing or, rather, crystal-inducing diets usually aim at
increasing the amount of oxalate that is filtered at the
glomerulus, thereby resembling primary forms of hyper-
oxaluria rather than idiopathic forms of calcium oxalate
nephrolithiasis. High oxalate in ultrafiltrate may already
lead to the formation of crystals in the proximal tubule
and thus inevitably to crystal binding and uptake. Follow-
ing this train of thought, it is reasonable to assume that
evolution provided those areas of the urinary tract in
which the urine can be very concentrated with a crystal-
repulsive epithelial lining. Previously, we found that an
intact monolayer formed by late nephron MDCK-I cells
indeed is nonadherent to COM crystals. These anti-adher-
ence properties were temporarily lost, however, during
the healing of wounds made in confluent monolayers
[24]. Evidence was provided that during tissue repair
and remodeling, crystals adhered to the HA-rich zones
surrounding the wounded areas [9]. From these observa-
tions it was speculated that crystal binding in late seg-
ments of the nephron and remaining part of the urinary
tract requires some form of tissue damage [25, 26].
During the concentration process in the kidney, oxa-
late gradually increases from, on average, 2 mol/L in
ultrafiltrate to approximately 300mol/L in the final urine.
Oxalate is poorly soluble in the tubular fluid and calcium
oxalate crystals are occasionally formed in anyone’s kid-
neys. Although it is difficult to exactly pinpoint the seg-
ment in the nephron where crystal formation takes place,
it is assumed to occur somewhere beyond the thin limbs
[27–29]. Hence, proximal tubular cells are not used to
encounter crystals, which might explain why this epithe-
lium is not provided with an anti-adherent surface. How-
ever, the concentration of oxalate can be 10 to 20 times
higher in plasma of patients suffering from inborn errors
of oxalate metabolism [30]. Because the upper limits
of supersaturation in the primary urine depend on the
amount of oxalate that is filtered at the glomerulus, it is
plausible that crystals are formed earlier in the nephrons
of these patients. This implies that, in primary hyperoxal-
uria, crystals are formed at sites in the nephron where
the epithelium is not protected against their adherence.
The essence of the present study is not the observation
that crystals adhere to HA or to other cell surface constit-
uents, but that certain cell types constitutively bind and
take up crystals, whereas others do not. The possibility
that crystal binding and uptake cannot be avoided in proxi-
mal tubules and that epithelial injury–induced binding
in the collecting ducts does not involve crystal uptake may
have consequences for the treatment of the various forms
of renal stone disease. In patients suffering from primary
forms of hyperoxaluria, measures should be taken to
avoid crystal adherence in the proximal tubule, whereas
in idiopathic recurrent calcium oxalate renal stone dis-
ease, the best approach could be the prevention of tissue
damage in the distal tubule and/or collecting ducts.
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